Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 18 studies | 24% ± 9% | |
smooth muscle cell | 16 studies | 23% ± 7% | |
astrocyte | 14 studies | 31% ± 13% | |
epithelial cell | 9 studies | 34% ± 14% | |
basal cell | 7 studies | 33% ± 21% | |
myofibroblast cell | 6 studies | 26% ± 9% | |
goblet cell | 6 studies | 27% ± 13% | |
podocyte | 5 studies | 42% ± 10% | |
fibroblast | 5 studies | 23% ± 5% | |
epithelial cell of proximal tubule | 4 studies | 24% ± 7% | |
abnormal cell | 4 studies | 27% ± 3% | |
ciliated cell | 4 studies | 23% ± 3% | |
brush cell | 4 studies | 23% ± 5% | |
club cell | 4 studies | 24% ± 9% | |
GABAergic neuron | 3 studies | 30% ± 8% | |
ependymal cell | 3 studies | 39% ± 11% | |
connective tissue cell | 3 studies | 40% ± 29% | |
enterocyte | 3 studies | 18% ± 1% | |
transit amplifying cell | 3 studies | 43% ± 35% | |
adipocyte | 3 studies | 32% ± 8% | |
parietal epithelial cell | 3 studies | 51% ± 5% | |
renal principal cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 10859.87 | 965 / 966 | 99% | 85.09 | 521 / 527 |
esophagus | 99% | 6127.67 | 1426 / 1445 | 98% | 102.10 | 180 / 183 |
stomach | 99% | 4006.78 | 357 / 359 | 97% | 86.65 | 278 / 286 |
prostate | 100% | 6103.63 | 245 / 245 | 94% | 57.39 | 474 / 502 |
pancreas | 98% | 4157.31 | 323 / 328 | 95% | 54.71 | 169 / 178 |
kidney | 100% | 9502.22 | 89 / 89 | 93% | 73.53 | 838 / 901 |
lung | 99% | 5286.49 | 575 / 578 | 92% | 45.85 | 1066 / 1155 |
bladder | 100% | 6486.90 | 21 / 21 | 91% | 52.88 | 457 / 504 |
brain | 93% | 3241.21 | 2458 / 2642 | 90% | 35.53 | 637 / 705 |
uterus | 97% | 5204.80 | 165 / 170 | 86% | 38.09 | 393 / 459 |
breast | 100% | 6402.96 | 458 / 459 | 82% | 38.45 | 913 / 1118 |
skin | 100% | 11846.95 | 1808 / 1809 | 81% | 29.51 | 384 / 472 |
thymus | 100% | 4891.53 | 651 / 653 | 61% | 16.55 | 369 / 605 |
ovary | 96% | 3620.70 | 173 / 180 | 58% | 12.68 | 251 / 430 |
liver | 68% | 2554.62 | 153 / 226 | 72% | 24.51 | 291 / 406 |
blood vessel | 100% | 9550.50 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.00 | 1 / 1 |
adipose | 100% | 5403.03 | 1202 / 1204 | 0% | 0 | 0 / 0 |
heart | 93% | 4599.45 | 801 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 26.78 | 70 / 80 |
tonsil | 0% | 0 | 0 / 0 | 80% | 50.37 | 36 / 45 |
adrenal gland | 6% | 90.36 | 15 / 258 | 22% | 5.63 | 50 / 230 |
muscle | 9% | 172.00 | 74 / 803 | 0% | 0 | 0 / 0 |
spleen | 5% | 77.23 | 13 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007163 | Biological process | establishment or maintenance of cell polarity |
GO_0003382 | Biological process | epithelial cell morphogenesis |
GO_0007155 | Biological process | cell adhesion |
GO_0007267 | Biological process | cell-cell signaling |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0007015 | Biological process | actin filament organization |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0002088 | Biological process | lens development in camera-type eye |
GO_0003412 | Biological process | establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0016477 | Biological process | cell migration |
GO_1904754 | Biological process | positive regulation of vascular associated smooth muscle cell migration |
GO_1904385 | Biological process | cellular response to angiotensin |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005925 | Cellular component | focal adhesion |
GO_0005911 | Cellular component | cell-cell junction |
GO_0030175 | Cellular component | filopodium |
GO_0005829 | Cellular component | cytosol |
GO_0030027 | Cellular component | lamellipodium |
GO_0005634 | Cellular component | nucleus |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FAT1 |
Protein name | FAT atypical cadherin 1 Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] Alternative protein FAT1 |
Synonyms | FAT CDHF7 |
Description | FUNCTION: [Protocadherin Fat 1]: Plays an essential role for cellular polarization, directed cell migration and modulating cell-cell contact. . |
Accessions | D6RHE6 ENST00000509537.1 H0Y9C8 D6RCE4 ENST00000512772.5 ENST00000441802.7 H0Y9H4 L8E7S1 H0Y8F5 ENST00000509927.1 ENST00000507105.1 ENST00000509647.1 Q14517 |